Toll-like receptor agonists have hit another setback with the Phase II failure of Idera's IMO-2055, but these immunotherapies may still make a comeback if appropriate combinations with vaccine ...
Inflammation that occurs after solid organ transplantation can precipitate acute allograft rejection, impede transplant tolerance and enhance the development of chronic allograft rejection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results